These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17016445)

  • 41. Targeting synuclein-gamma to counteract drug resistance in cancer.
    Singh VK; Jia Z
    Expert Opin Ther Targets; 2008 Jan; 12(1):59-68. PubMed ID: 18076370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dehydroepiandrosterone, androgens and the mammary gland.
    Labrie F
    Gynecol Endocrinol; 2006 Mar; 22(3):118-30. PubMed ID: 16835073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Journal of Mammary Gland Biology and Neoplasia. Preface.
    Ingman WV
    J Mammary Gland Biol Neoplasia; 2014 Jul; 19(2):147-8. PubMed ID: 24989703
    [No Abstract]   [Full Text] [Related]  

  • 44. Unconventional secretion of synuclein-γ promotes tumor cell invasion.
    Liu C; Qu L; Lian S; Tian Z; Zhao C; Meng L; Shou C
    FEBS J; 2014 Nov; 281(22):5159-71. PubMed ID: 25229320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic variation in sensitivity to estrogens and breast cancer risk.
    Jerry DJ; Shull JD; Hadsell DL; Rijnkels M; Dunphy KA; Schneider SS; Vandenberg LN; Majhi PD; Byrne C; Trentham-Dietz A
    Mamm Genome; 2018 Feb; 29(1-2):24-37. PubMed ID: 29487996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen-regulated transcription: Mammary gland and uterus.
    Vasquez YM
    Steroids; 2018 May; 133():82-86. PubMed ID: 29289754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imbalance between apoptosis and cell proliferation during early stages of mammary gland carcinogenesis in ACI rats.
    Kutanzi KR; Koturbash I; Bronson RT; Pogribny IP; Kovalchuk O
    Mutat Res; 2010 Dec; 694(1-2):1-6. PubMed ID: 20659487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mouse models of human breast cancer.
    Cardiff RD
    Comp Med; 2003 Jun; 53(3):250-3. PubMed ID: 12868567
    [No Abstract]   [Full Text] [Related]  

  • 49. Tetratricopeptide repeat domain 9A negatively regulates estrogen receptor alpha activity.
    Shrestha S; Sun Y; Lufkin T; Kraus P; Or Y; Garcia YA; Guy N; Ramos P; Cox MB; Tay F; Lin VC
    Int J Biol Sci; 2015; 11(4):434-47. PubMed ID: 25798063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxalate induces breast cancer.
    Castellaro AM; Tonda A; Cejas HH; Ferreyra H; Caputto BL; Pucci OA; Gil GA
    BMC Cancer; 2015 Oct; 15():761. PubMed ID: 26493452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gamma-synuclein: cell-type-specific promoter activity and binding to transcription factors.
    Surgucheva I; Surguchov A
    J Mol Neurosci; 2008 Jul; 35(3):267-71. PubMed ID: 18498014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insight into residues involved in the structure and function of the breast cancer associated protein human gamma synuclein.
    Manivel P; Muthukumaran J; Kannan M; Krishna R
    J Mol Model; 2011 Feb; 17(2):251-63. PubMed ID: 20437261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex steroid-dependent and -independent action of hydroxysteroid (17beta) Dehydrogenase 2: evidence from transgenic female mice.
    Shen Z; Saloniemi T; Rönnblad A; Järvensivu P; Pakarinen P; Poutanen M
    Endocrinology; 2009 Nov; 150(11):4941-9. PubMed ID: 19797119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role and Characterization of Synuclein-γ Unconventional Protein Secretion in Cancer Cells.
    Liu C; Qu L; Shou C
    Methods Mol Biol; 2016; 1459():215-27. PubMed ID: 27665562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.
    Tastekin D; Kargin S; Karabulut M; Yaldız N; Tambas M; Gurdal N; Tatli AM; Arslan D; Gok AF; Aykan F
    Tumour Biol; 2014 Dec; 35(12):11871-7. PubMed ID: 25142230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synuclein gamma expression enhances radiation resistance of breast cancer cells.
    Tian L; Zhao Y; Truong MJ; Lagadec C; Bourette RP
    Oncotarget; 2018 Jun; 9(44):27435-27447. PubMed ID: 29937996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dimebon reduces the levels of aggregated amyloidogenic protein forms in detergent-insoluble fractions in vivo.
    Ustyugov AA; Shelkovnikova TA; Kokhan VS; Khritankova IV; Peters O; Buchman VL; Bachurin SO; Ninkina NN
    Bull Exp Biol Med; 2012 Apr; 152(6):731-3. PubMed ID: 22803176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sensitivity of the mammary gland to oestrone in different strains of mice with and without mammary tumour agent.
    MUHLBOCK O
    Acta Endocrinol (Copenh); 1949; 3(2):105-10. PubMed ID: 15397389
    [No Abstract]   [Full Text] [Related]  

  • 59. [The association of gamma-synuclein autoantibodies with the polymorphism in exon 4 of the coding gene].
    Maltsev AV; Borodina YV; Skuratovskaya LN; Kukharsky MS; Ovchinnikov RK; Razinskaya OD; Smirnov AP; Kovrazhkina EA; Ustyugov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):68-70. PubMed ID: 30335075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of adrenalectomy on the mammary gland of the castrated and estrogen treated castrated male rat.
    TRENTIN JJ; TURNER CW
    Endocrinology; 1947 Aug; 41(2):127-34. PubMed ID: 20266708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.